Angiopoietin-1 increases arteriolar vasoconstriction to phenylephrine during sepsis

Regul Pept. 2005 Nov;131(1-3):34-7. doi: 10.1016/j.regpep.2005.06.006.

Abstract

Sepsis leads to a reduction in vascular tone and a loss of vasoconstriction in response to catecholamines. We propose that angiopoietin-1 (Ang-1), which is known to modulate vascular inflammation and nitric oxide (NO), could improve responsiveness to vasopressor agents during sepsis. Mesenteric arterioles (300-400 microm) from rats (n=19) were mounted in a pressurized myograph and incubated with lipopolysaccharide (LPS, 50 microg/mL) for up to 4 h to model sepsis. Vasoconstriction (mean+/-SD) to phenylephrine (10(-8)-10(-3) M) was reduced in the presence of LPS (4 h, pD2: 5.8+/-0.2 (controls, n=6), 1.4+/-2.2 (LPS, n=6); maximal constriction: 48.2+/-4.8% (controls), 2.6+/-5.8% (LPS), P<0.05). However, in the presence of Ang-1 (250 ng/mL) phenylephrine caused greater vasoconstriction compared to LPS alone (4 h, pD2: 4.5+/-2.1; maximal constriction: 12.6+/-4.0% (n=7), P<0.05). In conclusion, Ang-1 increases vasoconstriction to phenylephrine in the presence of LPS. During sepsis therefore, Ang-1 increases vascular reactivity and has the potential to increase blood pressure and decrease vasopressor requirements in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-1 / metabolism
  • Angiopoietin-1 / pharmacology*
  • Animals
  • Arterioles / drug effects*
  • Arterioles / metabolism
  • In Vitro Techniques
  • Lipopolysaccharides / pharmacology
  • Male
  • Mesentery / blood supply
  • Phenylephrine / metabolism
  • Phenylephrine / pharmacology*
  • Rats
  • Rats, Wistar
  • Sepsis / metabolism*
  • Vasoconstriction / drug effects*
  • Vasoconstrictor Agents / metabolism
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Angiopoietin-1
  • Lipopolysaccharides
  • Vasoconstrictor Agents
  • Phenylephrine